CA Patent

CA2601694A1 — Enhancement of macrolide penetration through human skin

Assigned to Macrochem Corp · Expires 2006-09-21 · 20y expired

What this patent protects

The addition of a skin modifying agent to a macrolide having molecular weight between 500 and 1200 Daltons unexpectedly improves the delivery of the macrolide through human skin when compared to the drug mixed with alcohol alone. The skin modifying agent can be formulated with su…

USPTO Abstract

The addition of a skin modifying agent to a macrolide having molecular weight between 500 and 1200 Daltons unexpectedly improves the delivery of the macrolide through human skin when compared to the drug mixed with alcohol alone. The skin modifying agent can be formulated with suitable excipients to form a lotion, ointment, cream, or gel for treating psoriasis and other skin disorders.

Drugs covered by this patent

Patent Metadata

Patent number
CA2601694A1
Jurisdiction
CA
Classification
—
Expires
2006-09-21
Drug substance claim
No
Drug product claim
No
Assignee
Macrochem Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.